Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Disparities in lung cancer biomarker testing show barriers that delay diagnosis and treatment for lower-income patients, according to Sandip P. Patel, MD. Patients with lower socioeconomic status were ...

Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...

NHS England » NHS launches trailblazing AI and robot pilot to spot lung cancer sooner alongside screening programme set to tackle cancer inequalities ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.